Internal Medicine, Nephrology · Bay Shore, NY
NPI
1851492904
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
340 Howells Rd, Suite A
Bay Shore, NY, 11706
Phone (631) 666-2808
Groups this clinician bills Medicare through
Medicare paid, 2024
$409K
5,899 services
Medicare patients, 2024
1,030
Average age 76
Drug cost, 2024
$320K
1,030 prescriptions
Company payments, 2023
$61.81
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen R Bernhardt was code J0885 (injection, epoetin alfa, (for non-esrd use), 1000 units), 2,480 times for 31 patients. In total Stephen R Bernhardt billed 5,899 services in 31 codes, and Medicare paid $409K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-24.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,480 | 31 | $6.26 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 1,314 | 496 | $75.44 | $99K |
| 99214 Office E&M - Established | Office | 590 | 305 | $117.29 | $69K |
| 90935 Hemodialysis | Facility | 334 | 151 | $66.96 | $22K |
| 99222 Hospital E&M - Initial | Facility | 290 | 267 | $125.85 | $36K |
| 90960 ESRD Related Services (not dialysis) | Office | 289 | 83 | $318.07 | $92K |
| 99233 Hospital E&M - Subsequent | Facility | 104 | 58 | $113.41 | $12K |
| 90961 ESRD Related Services (not dialysis) | Office | 94 | 43 | $264.13 | $25K |
| 99204 Office E&M - New | Office | 71 | 71 | $151.70 | $11K |
| 96372 Injection Administration | Office | 62 | 31 | $13.67 | $848 |
| 99213 Office E&M - Established | Office | 51 | 42 | $77.58 | $3,956 |
| 90945 Peritoneal Dialysis | Facility | 33 | 14 | $81.98 | $2,705 |
| 90966 ESRD Related Services (not dialysis) | Office | 33 | 14 | $254.39 | $8,395 |
| 81003 Clinical Chemistry | Office | 28 | 28 | $2.20 | $61.6 |
| 99231 Hospital E&M - Subsequent | Facility | 20 | 20 | $47.67 | $953 |
By year: 2022 $426K for 5,531 services; 2023 $419K for 5,214 services; 2024 $409K for 5,899 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 28 | 28 | $2.20 | $61.6 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen R Bernhardt prescribed most often to Medicare patients was Sevelamer Carbonate, with 97 prescriptions and refills. In total Stephen R Bernhardt wrote 1,030 Medicare prescriptions that cost $320K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 97 | 185 | 33 | $15K |
| Velphoro Sucroferric Oxyhydroxide | 60 | 90 | 20 | $152K |
| Amlodipine Besylate Generic | 59 | 172 | 26 | $157 |
| Losartan Potassium Generic | 28 | 80 | 11 | $212 |
| Dextrose 5%-0.9% Nacl Dextrose 5 % And 0.9 % Nacl | 28 | 28 | Under 11 | $1,031 |
| Torsemide Generic | 27 | 81 | 15 | $336 |
| Calcium Acetate Generic | 27 | 57 | Under 11 | $1,514 |
| Allopurinol Generic | 25 | 65 | 13 | $204 |
| Hydralazine Hcl Generic | 24 | 72 | 11 | $432 |
| Farxiga Dapagliflozin Propanediol | 23 | 58 | Under 11 | $32K |
| Metoprolol Succinate Generic | 23 | 67 | Under 11 | $306 |
| Tamsulosin Hcl Generic | 23 | 57 | Under 11 | $220 |
| Potassium Chloride Generic | 22 | 52 | Under 11 | $599 |
| Furosemide Generic | 20 | 45 | 12 | $135 |
| Atorvastatin Calcium Generic | 20 | 60 | Under 11 | $257 |
Brand drugs: - claims; generic drugs: 817 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Stephen R Bernhardt $61.81 ($61.81 in general payments such as food, travel and fees) from 3 companies. The largest payer was Calliditas Therapeutics US Inc. with $27.2.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.